China Vaccine Market Report, 2007-2009

China Vaccine Market Report, 2007-2009

China is the largest vaccine producer and consumer in the world. According to the statistics of the General Administration of Customs, China's total vaccine import and export volume reached 34,846 tons in the first five months of 2008, of which 7,735 tons were imports, and 27,111 tons were exports. China's total vaccine import and export value in the same period was US$217.52 million, of which US$197.73 million was import value, and US$19.79 million was export value.

In 2007, China's total vaccine import and export volume reached 2,320 tons, of which 1,500 tons were imports, 820 tons were exports. China's total vaccine import and export value hit US$386.79 million, of which US$344.28 million was import value, and US$42.51 million was export value.

Based on the authoritative statistics of the National Bureau of Statistics, the State-Owned Assets Supervision and Administration Commission, the State Information Center, the Development Research Center of the State Council, the China Pharmaceutical Association, and the General Administration of Customs, this report makes in-depth analysis on China bio-pharmaceutical industry development, vaccine market, impact of SARS on vaccine market, vaccine import & export, key vaccine markets, key vaccine producers, investment opportunities and also makes forecast on the development trend of China's vaccine industry.

1. China Vaccine Market in Globalization Process
1.1 Impact of Globalization on China Pharmaceutical Market
1.1.1 Pharmaceutical Industry Restructuring and International Division of Labor
1.1.2 Accelerated Globalization Process of Pharmaceutical Market
1.1.3 International Status of China Pharmaceutical Industry
1.1.4 Forecast of China Status in Global Pharmaceutical Industry, 2009
1.2.1 China Vaccine Market
1.2.2 Policy on Foreign Capital Entry into China Vaccine Market
1.2.3 Competition Strategies of Chinese Vaccine Companies
1.3 China Vaccine Market Position in the Global Market

2. China Vaccine Market Development in 2008-2009
2.1 Market Characteristics, 2008
2.2 Main Vaccines Types, 2008
2.3 Market Structure, 2008
2.4 Market Characteristics, 2008
2.5 Market Development Trend, 2008
2.6 Suggestions for Vaccine Industry Development, 2008

3. Market of Main Varieties of Vaccine, 2008
3.1 China Flu Vaccine Market, 2008
3.1.1 Market Background
3.1.2 Research and Development
3.1.3 Market Size
3.1.4 Competition
3.1.5 Market Demand
3.1.6 Key Producers
3.2 China HBV Vaccine Market
3.2.1 Market Background
3.2.2 Market Size
3.2.3 Main Products
3.2.3.1 Plasma Derived HB Vaccine
3.2.3.2 Recombinant HB Vaccine
3.2.3.3 Recombinant Vaccine of HB Virus Surface Antigens(CHO cell)
3.2.3.4 New Type of HBV
3.2..4 Market Price
3.2.5 Key Producers
3.3 China Epidemic Cerebrospinal Meningitis Vaccine Market
3.3.1 Market Background
3.3.2 Market Size
3.3.2 Key Producers
3.4 China AIDS Vaccine Market
3.4.1 Market Background
3.4.2 Market Size
3.4.3 Research and Development
3.4.3.1 China Research on AIDS Vaccine
3.4.3.2 Research Direction
3.4.3.5 Process of Research Projects
3.5 China Bird Flu Vaccine Market
3.5.1. Market Background
3.5.2 Research and Development
3.5.3 Key Producers
3.6 Other Vaccine Market and Research and Development
3.6.1 Lung Cancer Vaccine
3.6.1.1 Tumor Cell Vaccine
3.6.1.2 Anti Tumor Antigen Vaccine
3.6.1.3 Anti-idiotypic Vaccine
3.6.1.4 DNA Vaccine
3.6.1.5 Dendritic Cell Vaccine
3.6.1.6 Peptide Vaccine
3.6.2 China Measles Vaccine Market
3.6.3 China Research on Cervical Cancer Vaccine
3.6.4 China Research on Lupus Erythematosus Vaccine
3.6.5 China Research on Rotavirus Vaccine
3.6.6 Principle of Tumor Vaccine
3.7 China Animal Vaccine Market
3.7.1 Development Advantages
3.7.1.1 Basis of Demand
3.7.1.2 Green Barriers: Promotion of Animal Vaccine
3.7.1.3 Market Background of and Demand for Pet Vaccine
3.7.1.4 Key Producers
3.7.2 Research Progress in Vaccine for Animal Use
3.7.2.1 Research and Development of Animal Virus Vaccine
3.7.2.2 R&D Bases of China Animal Vaccine
3.7.2.3 Successful Development of Purified Rabies Vaccine for Human Use
3.7.2.4 Research Progress in Pseudorabies Gene-deleted Vaccine

4. Impact of SARS on Vaccine Market
4.1 Vaccine Market Activated by SARS
4.1.1 Booming of Vaccine Industry
4.1.2 Bottleneck of Vaccine Industry
4.1.3 Research and Development of SARS Vaccine
4.2 Dispute of SARS Patent and Market
4.3 Patent Protection Measures on Anti SARS Vaccine

5. Import and Export of China Vaccine
5.1 General Trend of Vaccine Trade
5.3 Vaccine Export Regions Structure
5.4 Trade Methods Structure of Vaccine
5.5 Comparison between Imported Vaccine and Homemade Vaccine

6. China Key Vaccine Producers
6.1 Main Vaccine Companies
6.1.1 China National Biotech Group Co., Ltd
6.1.1.1 Company Profile
6.1.1.2 Operation Status
6.1.2 Beijing Tiantan Biological Products Co., Ltd.
6.1.2.1 Company Profile
6.1.2.2 Operation Status
6.1.3 Shanghai Institute of Biological Products
6.1.4 Shenzhen Kangtai Biological Products Co., Ltd
6.1.5 Changchun Changsheng Life Sciences Co., Ltd
6.1.6 Shenzhen Neptunus Bioengineering Co., Ltd
6.1.6.1 Company Profile
6.1.6.2 Operation Status
6.1.7 Guangxi Beisheng Pharmaceutical Co., Ltd.
6.1.7.1 Company Profile
6.1.7.2 Operation Status
6.1.8 Star Lake Bioscience Co., Ltd
6.1.8.1 Company Profile
6.1.8.2 Operation Status
6.1.9 Shanghai Fosun Pharmaceutical (Group) Co., Ltd
6.1.9.1 Company Profile
6.1.9.2 Operation Status

7. Vaccine Market Development Trend and Forecast, 2009
7.1 Latest Information on Vaccine Research and Development
7.1.1 Development Trend of New Type of Vaccine
7.1.2 New Types of Vaccines
7.1.2.1 Sub-unit Vaccine
7.1.2.2 Gene Recombination Vaccine
7.1.2.3 Synthetic Vaccine
7.1.2.4 Immunoglobulin Carrier Vaccine
7.1.3 Research and Development of New Type of Vaccine
7.1.3.1 Vaccine for Prevention of Respiratory Disease
7.1.3.2 Vaccine for Prevention of Digestive Disease
7.1.3.3 Vaccine for Prevention of Arbo Infectious Disease
7.1.4 New Type of Combined Vaccine
7.1.4.1 Development History
7.1.4.2 Applications and Problems of Combined Vaccine
7.1.4.3 Development of Combined Vaccine
7.1.4.4 Taking Oral Combined Vaccine
7.1.4.5 Immunity of Measles
7.1.4.6 Immunity of Mumps
7.1.4.7 Application of Varicella Vaccine
7.2 Forecast of Varicella Vaccine Market, 2009

8. Operation Status of Biopharmaceutical Industry
8.1 Operation Status, 2007
8.1.1 Output Value and Its Changes, 2007
8.1.2 Sales Revenue and Its Changes, 2007
8.1.3 Total Output Value and Its Changes, 2007
8.1.4 Changes in the Number of Key Producers, 2007
8.1.5 Profit and Its Changes, 2007
8.2 Business Operation of Top Ten Companies, 2007
8.2.1 Changes in Sales Revenue of Top Ten Companies, 2007
8.2.2 Changes in Assets of Top Ten Companies, 2007
8.2.3 Changes in Profit of Top Ten Companies, 2007
8.2.4 Changes in Employees of Top Ten Companies, 2007




Flu Vaccine Proportion in Main Vaccine Market
Flu Vaccine Producers Overseas
Flu Vaccine Producer at Home
China Key Vaccine Producers and Products
Virus Vaccine-Split Influenza Virus Vaccine's Dosage Form, Price & Origin, 2008
HB Vaccine Proportion in Main Vaccine Market
Virus Vaccine-Recombinant Vaccine of HB's (CHO cell)Dosage Form, Price & Origin, 2008
Virus Vaccine-Recombinant Vaccine of HB's (Barm) Dosage Form, Price & Origin, 2008
Main HB Vaccine Producers
Morbidity & Mortality of 27 kinds of Infectious Diseases Reported Statutorily
Main Regions of Epidemic Cerebrospinal Meningitis
Total Volume of Epidemic Cerebrospinal Meningitis Vaccine Put into Anhui Province and Jiangsu Province
Statistics of China HIV-infected Patients
Informed Rate of China HIV-infected Patients
Forecast of China Future AIDS Vaccine Market
Profit Margin of Bird Flue Vaccine
Comparison of Import Value between Anti-serum and Vaccine in 2007-2008
Comparison of Import Volume between Anti-serum and in 2007-2008
Anti-serum and Vaccine Export Value, 2007-2008
Anti-serum and Vaccine Export Volume, 2007-2008
Profitability of Beijing Tiantan Biological Products Co., 2007-2008
Operation Ability of Beijing Tiantan Biological Products Co., 2007-2008
Debt-paying Ability of Beijing Tiantan Biological Products Co., 2007-2008
Capital Structure of Beijing Tiantan Biological Products Co., 2007-2008
Development Ability of Beijing Tiantan Biological Products Co., 2007-2008
Cash Flow of Beijing Tiantan Biological Products Co., 2007-2008
Profitability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Operation Ability of Shenzhen Neptunus Bioengineering Co.,2007-2008
Debt-paying Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Capital Structure of Shenzhen Neptunus Bioengineering Co., 2007-2008
Development Ability of Shenzhen Neptunus Bioengineering Co., 2007-2008
Cash Flow of Beijing Shenzhen Neptunus Bioengineering Co., 2007-2008
Profitability of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Operation Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Debt-paying Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Capital Structure of Guangxi Beisheng Pharmaceutical Co.,2007-2008
Development Ability of Guangxi Beisheng Pharmaceutical Co., 2007-2008
Cash Flow of Beijing Guangxi Beisheng Pharmaceutical Co., 2007-2008
Profitability of Star Lake Bioscience Co., 2007-2008
Operation Ability of Star Lake Bioscience Co., 2007-2008
China Top 10 Pharmaceutical Giants, 2007
Hepatitis Vaccine Market Size Forecast, 2009
Vaccine for Children Market Forecast, 2009
Vaccine for Adults and Flu Vaccine Market Forecast,2009
Therapeutic Vaccine Market Size Forecast, 2009